I took a look at the MDR prospectus today to try and understand the business model.
A company called Macmillan Gold and Associates Pty Ltd (ACN 166 795 277) has exclusive rights to sign GPs in NSW and SA subject to performance targets and associated performance rights. They're being offered up to 50m shares if they hit their targets.
I couldn't find any information about who they are or why they have any expertise WRT GPs.
So my question: who are MMR and why are they the right group to develop the GP revenue stream?
I took a look at the MDR prospectus today to try and understand...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $215.0M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 27.5¢ | $254.8K | 889.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39326 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 2917 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MDR (ASX) Chart |
